Segment Wealth Management’s Gilead Sciences GILD Stock Holding History

Segment Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-3,092	Closed	-$258K	–	162
2016 Q2	$258K	Hold	3,092	–	–	0.11%	121
2016 Q1	$284K	Sell	3,092 -100	-3%	-$9.02K	0.11%	113
2015 Q4	$323K	Sell	3,192 -400	-11%	-$41.6K	0.12%	107
2015 Q3	$353K	Sell	3,592 -200	-5%	-$22.2K	0.13%	109
2015 Q2	$444K	Buy	3,792 +1,135	+43%	+$124K	0.15%	99
2015 Q1	$261K	Sell	2,657 -25	-0.9%	-$2.54K	0.09%	147
2014 Q4	$253K	Sell	2,682 -16	-0.6%	-$1.66K	0.1%	130
2014 Q3	$287K	Sell	2,698 -478	-15%	-$46.8K	0.11%	134
2014 Q2	$263K	Buy	3,176 +47	+2%	+$3.66K	0.1%	146
2014 Q1	$222K	Buy	3,129 +275	+10%	+$21.6K	0.1%	145
2013 Q4	$214K	Buy	+2,854	New	+$199K	0.11%	147

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Segment Wealth Management's GILD Position: Q3 2016 in Review

Segment Wealth Management sold out of Gilead Sciences (GILD) in Q3 2016, closing a stake of 3,092 shares — an estimated $258K sold.

Segment Wealth Management first reported a position in GILD in Q4 2013 and held it in 11 quarters. The position peaked at $444K in Q2 2015. 1,557 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

Segment Wealth Management reported no remaining Gilead Sciences position as of Q3 2016 after selling out during the quarter.
Segment Wealth Management sold 3,092 Gilead Sciences shares in Q3 2016, an estimated $258K.
Segment Wealth Management first reported a position in Gilead Sciences in Q4 2013 and held it in 11 quarters.
Segment Wealth Management's Gilead Sciences position peaked at $444K in Q2 2015.
1,557 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on Segment Wealth Management's 13F filing for Q3 2016, filed 26 Oct 2016.